Dr. Bassel Nazha, M.D., MPH, earned his medical degree from the American University of Beirut in Beirut, Lebanon. Dr. Nazha completed a clinical fellowship in Hematology/Oncology at Emory University School of Medicine in Atlanta, GA. His postgraduate medical education also included residency training at Staten Island University Hospital - Hofstra Northwell School of Medicine in Staten Island, New York. Dr. Nazha received a Master of Public Health in Health Policy and Management from Columbia University in New York.
Dr. Bassel Nazha, M.D., MPH, earned his medical degree from the American University of Beirut in Beirut, Lebanon. Dr. Nazha completed a clinical fellowship in Hematology/Oncology at Emory University School of Medicine in Atlanta, GA. His postgraduate medical education also included residency training at Staten Island University Hospital - Hofstra Northwell School of Medicine in Staten Island, New York. Dr. Nazha received a Master of Public Health in Health Policy and Management from Columbia University in New York.
Dr. Bassel Nazha, M.D., MPH, joined Piedmont Cancer Institute in July of 2024. He earned his medical degree from the American University of Beirut in Beirut, Lebanon. Dr. Nazha completed a clinical fellowship in Hematology/Oncology at Emory University School of Medicine in Atlanta, Georgia, where he was Chief Fellow his final year. His postgraduate medical education also included residency training at Staten Island University Hospital - Hofstra Northwell School of Medicine in Staten Island, New York. Dr. Nazha received a Master of Public Health in Health Policy and Management from Columbia University in New York, New York. He also completed a Bachelor of Science in Biology at McGill University in Montreal, Canada, graduating with Great Distinction.
Dr. Nazha's research area of interest is working on novel therapeutic agents and biomarker development in genitourinary oncology. He is particularly interested in systemic treatment modalities that allow achieving higher cure rates in the non-metastatic setting, as part of a perioperative approach. He is focused on conducting outcomes research to elucidate treatment efficacy in real-world settings and on minority enrollment in cancer clinical trials. He has a great deal of experience in managing all types of cancer and hematologic disorders.
Dr. Nazha speaks English, French and Arabic. He enjoys traveling, sports, following current affairs, and spending time with his wife and children.